Real-world data confirms limited efficacy of dual anti-PD-1 and CTLA-4 immune checkpoint blockade in acral lentiginous melanoma.

IF 11 1区医学 Q1 DERMATOLOGY

British Journal of Dermatology Pub Date : 2024-11-15 DOI:10.1093/bjd/ljae445

David X Zheng, Russell W Jenkins

引用次数: 0

查看原文本刊更多论文

真实世界的数据证实了抗PD-1和CTLA-4双重免疫检查点阻断疗法对渐冻人黑色素瘤的有限疗效。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

British Journal of Dermatology 医学-皮肤病学

CiteScore

16.30

自引率

3.90%

发文量

1062

审稿时长

2-4 weeks

期刊介绍： The British Journal of Dermatology (BJD) is committed to publishing the highest quality dermatological research. Through its publications, the journal seeks to advance the understanding, management, and treatment of skin diseases, ultimately aiming to improve patient outcomes.